Abingdon Health’s core technology is based on rapid lateral flow immunoassay diagnostics and associated reader systems.
We are also developing the next generation of multiplexed rapid diagnostics technology to meet the market need for simple-to-use, rapid, cost effective, portable system.
There's many things to consider, and ask of you & your lateral assay development & manufacturing partner, to ensure… https://t.co/nec3t475EF
23 May 2018
© Abingdon Health 2018